Diabetic neuropathy is associated with increased long-term morbidity and revision risk following lumbar laminectomy or laminotomy Authors: Bashar Jawich, Tarek Harhash, Alqasim Elnaggar, Ahmad Almaat, Jawad Saad, Abdel Kareem Hilo, Haytham Alqasmi, Tyler Forbes, Rahul Vaidya Published: 2026 ABSTRACT BackgroundDiabetic neuropathy is a common microvascular complication of diabetes and may reflect systemic vulnerability that extends beyond peripheral nerve dysfunction. Its long-term impact on postoperative outcomes following lumbar laminectomy/laminotomy remains poorly characterized. This study aimed to evaluate the association between diabetic neuropathy and long-term postoperative complications, healthcare utilization, and revision surgery following lumbar laminectomy or laminotomy.MethodsUsing a nationwide federated research network, adults undergoing lumbar laminectomy or laminotomy were identified and stratified by the presence of diabetic neuropathy. One-to-one propensity score matching was performed to balance demographics, comorbidities, medications, and laboratory values. Longitudinal outcomes, including medical complications, healthcare utilization, and revision surgery, were assessed at 1, 5, and 10 years. Kaplan-Meier analysis was used to estimate revision-free survival.ResultsAfter matching, 19,265 patients with diabetic neuropathy were compared with 19,265 patients without neuropathy. Across all time horizons, diabetic neuropathy was associated with higher rates of adverse medical outcomes, including sepsis, venous thromboembolism, myocardial infarction, and cerebral infarction. Emergency department utilization remained consistently elevated in the neuropathy cohort at 1, 5, and 10 years. Revision lumbar surgery occurred more frequently among patients with diabetic neuropathy, with differences evident early and persisting over long-term follow-up. Kaplan-Meier analysis demonstrated significantly lower revision-free survival in patients with neuropathy compared with matched controls over 10 years. Findings remained directionally consistent in a sensitivity analysis using a stricter comparator cohort restricted to patients without diabetic complications.ConclusionsIn this large, propensity-matched cohort, diabetic neuropathy was associated with a sustained increase in medical complications, healthcare utilization, and revision surgery following lumbar laminectomy or laminotomy. These findings suggest that diabetic neuropathy represents a marker of long-term postoperative vulnerability rather than isolated perioperative risk and may warrant consideration in preoperative risk stratification and longitudinal care planning. Highlight box Key findings • Diabetic neuropathy is associated with higher rates of medical complications, emergency department utilization, and revision surgery following lumbar laminectomy or laminotomy. These differences persist across short-, mid-, and long-term follow-up (1, 5, and 10 years). Neuropathy is associated with reduced revision-free survival over time. What is known and what is new? • Diabetes is associated with worse outcomes after spine surgery, including higher complication rates and impaired recovery. Prior studies typically evaluate diabetes broadly without isolating diabetic neuropathy as a distinct risk factor. • This study provides a large, propensity-matched analysis isolating diabetic neuropathy as a distinct exposure with up to 10-year follow-up. This study demonstrates that neuropathy is associated with sustained long-term morbidity and increased procedural burden. What is the implication, and what should change now? • Diabetic neuropathy should be considered a clinically meaningful risk marker beyond glycemic control alone. • Preoperative counseling should incorporate neuropathy status when discussing long-term expectations. Introduction Lumbar spinal stenosis and degenerative lumbar disease are common causes of leg-dominant pain and walking intolerance in older adults (1,2). Together, these conditions represent a frequent source of disability and reduced independence in this population. Gradual narrowing of the central canal and lateral recesses leads to symptoms over time. Facet degeneration, thickening of the ligamentum flavum, and progressive disc changes are common contributors (3). If nonoperative care fails to control symptoms, many patients proceed to surgical decompression. When patients are carefully selected, many report less pain, improved walking tolerance, and an easier time with everyday activities after decompression. Laminectomy (with or without laminotomy or partial medial facetectomy) is a core decompressive procedure used to widen the spinal canal, relieve neural compression, and improve walking tolerance (4). For lumbar stenosis, it remains one of the most commonly performed lumbar operations in older adults. Across a range of patient populations, most carefully selected patients experience less pain and better function after (5,6). At the same time, long-term follow-up studies show that durable benefit is not universal, and a subset of patients develop persistent symptoms, recurrent stenosis, or require subsequent interventions over time (7,8). One of the parallel realities is that the typical lumbar stenosis population increasingly overlaps with patients who have several cardiometabolic comorbidity conditions, like type 2 diabetes mellitus (9). Diabetes is clinically relevant in spine care not only because it is common, but because it often coexists with systemic conditions that can shape perioperative risk and longer-term recovery trajectories. In the Spine Patient Outcomes Research Trial (SPORT), diabetic patients with spinal stenosis and degenerative spondylolisthesis still benefited from surgery compared with nonoperative care, yet postoperative complications were more prevalent in diabetics in certain subgroups (10). These findings support decompression as an effective therapy in diabetics while also reinforcing the need to refine risk stratification within this broad and heterogeneous population. Diabetic neuropathy represents a distinct manifestation of diabetes that reflects cumulative microvascular and neural injury rather than glycemic control alone (11). Neuropathy is associated with impaired protective sensation, altered gait mechanics, and diminished neuromuscular control, factors that may plausibly influence postoperative rehabilitation and functional recovery following lumbar laminectomy/laminotomy (12). In addition, diabetic neuropathy frequently coexists with microvascular dysfunction and inflammatory dysregulation, processes implicated in impaired tissue perfusion and delayed wound healing (13,14). Across orthopaedic subspecialties, peripheral neuropathy has been associated with higher rates of surgical site infection compared with patients without neuropathy, suggesting it may serve as a clinically relevant marker of increased perioperative risk (15). Large lumbar laminectomy/laminotomy studies rarely examine neuropathy as a separate exposure, despite evidence suggesting it may affect outcomes. Even with longer follow-up, most studies still group neuropathy together with diabetes. As a result, it is hard to tell whether neuropathy on its own affects outcomes. Even in studies with longer follow-up, neuropathy is usually lumped together with diabetes, making it difficult to know whether neuropathy itself drives outcomes. Propensity-matched observational designs are well suited to tackle this by balancing baseline differences. Despite this, there remains a lack of literature regarding long-term (5- and 10-year) outcomes following lumbar laminectomy or laminotomy stratified by the presence of diabetic neuropathy. This limitation is clinically relevant, as questions surrounding the durability of symptom relief, risk of recurrent stenosis, need for revision surgery, and long-term complication burden frequently extend well beyond the first postoperative year. Consequently, large-scale longitudinal real-world evidence isolating diabetic neuropathy as an exposure is needed to more precisely quantify its association with medical complications and downstream spine-specific outcomes, and to better inform perioperative risk stratification and shared decision-making in this growing patient population. We present this article in accordance with the STROBE reporting checklist (available at https://jss.amegroups.com/article/view/10.21037/jss-2026-1-0046/rc). Methods Data source This retrospective cohort study was conducted using the TriNetX Research Network, a federated research platform that aggregates de-identified electronic health record data from participating healthcare organizations, predominantly within the United States. The database includes longitudinal patient-level information encompassing demographics, diagnoses, procedures, medications, laboratory values, and clinical encounters. The study was conducted in accordance with the Declaration of Helsinki and its subsequent amendments. Cohort identification Adult patients aged 18 years or older who underwent lumbar decompression surgery were identified using Current Procedural Terminology (CPT) codes for lumbar laminotomy and laminectomy, including CPT 63030 and CPT 63047. The date of the first qualifying lumbar laminectomy/laminotomy procedure was defined as the index event. To ensure longitudinal follow-up, patients were required to have at least one documented clinical encounter occurring a minimum of 6 months after the index procedure. Patients whose index event occurred more than 20 years prior to the analysis date were excluded, consistent with TriNetX platform constraints. A STROBE-compliant flow diagram illustrating cohort selection is provided in Figure 1. STROBE-compliant flow diagram illustrating cohort selection, application of inclusion and exclusion criteria, and final propensity score-matched cohorts of patients with and without diabetic neuropathy undergoing lumbar laminectomy or laminotomy. T2DM, type 2 diabetes. Exposure classification The exposure of interest was the presence of diabetic neuropathy. Patients with type 2 diabetes mellitus and documented neurological complications were identified using ICD-10-CM code E11.4 and assigned to the diabetic neuropathy cohort. The comparator cohort consisted of patients with type 2 diabetes mellitus without documented neurological complications, identified using ICD-10-CM codes E11.0–E11.9 while explicitly excluding E11.4. Cohort definitions were derived from diagnosis codes recorded at or before the index event, with the full list of ICD-10-CM, CPT, and ICD-10-PCS codes used in the query provided in Table S1. Outcomes Outcomes were assessed at 1, 5, and 10 years following the index lumbar decompression procedure using separate analytic time windows. Time windows began 1 day after the index event and extended to 365, 1,825, or 3,650 days, respectively, depending on the analysis horizon. The primary outcome was revision lumbar surgery, defined as any subsequent lumbar reoperation including re-exploration laminotomy or repeat decompression identified using CPT and ICD-10-PCS procedure codes. Secondary outcomes included postlaminectomy syndrome, postlaminectomy kyphosis, recurrent lumbar spinal stenosis, postoperative infection, emergency department (ED) encounters, sepsis, venous thromboembolism (VTE) (pulmonary embolism or deep vein thrombosis), myocardial infarction, and cerebral infarction. Outcomes were identified using relevant ICD-10-CM diagnosis codes and CPT procedure codes recorded during follow-up encounters. Covariates Baseline covariates included demographic variables (age, sex, race, and ethnicity) and comorbid conditions commonly associated with diabetes severity and surgical risk, including obesity, hypertensive disease, ischemic heart disease, cerebrovascular disease, thyroid disorders, metabolic disorders, and tobacco use. To better account for baseline glycemic control and diabetes severity, available laboratory and treatment-related variables were incorporated when present. Some of these include body mass index (BMI), hemoglobin A1c (HbA1c), estimated glomerular filtration rate (eGFR), and metformin use. Covariates were selected a priori based on clinical relevance and prior literature evaluating outcomes following lumbar spine surgery. Propensity score matching To mitigate confounding, one-to-one propensity score matching was performed between patients with diabetic neuropathy and those without neuropathy. Propensity scores were generated using logistic regression models incorporating all baseline demographic, comorbidity, medication, and laboratory covariates. As mentioned previously, additional covariates were added, like insulin and metformin use, to improve the adjustment for diabetes severity. Nearest-neighbor matching without replacement was applied using a caliper width of 0.1 (the fixed value on the TriNetX platform) pooled standard deviations of the logit of the propensity score. Covariate balance before and after matching was assessed using standardized mean differences, with values less than 0.1 indicating adequate balance. Sensitivity analysis To address potential heterogeneity in the primary comparator cohort, a prespecified sensitivity analysis was conducted using a stricter control definition. In this secondary analysis, the comparator cohort was restricted to patients with type 2 diabetes mellitus without complications (ICD-10-CM E11.9) and explicitly excluded patients with ketoacidosis, kidney complications, ophthalmic complications, neurological complication, circulatory complications, other specified complications, and unspecified complications (ICD-10-CM E11.1, E11.2, E11.3, E11.4, E11.5, E11.6, and E11.8). The same inclusion criteria, propensity score matching strategy, covariates, and outcome definitions as the one in the primary analysis were used for this sensitivity analysis. Statistical analysis Laboratory and medication variables were not available for all patients and were included when present. Analyses were conducted using a complete-case approach based on data availability within the platform. Categorical outcomes were summarized as risks and compared between cohorts using risk ratios with corresponding 95% confidence intervals. Kaplan-Meier survival analyses were performed to evaluate time-to-event outcomes, including revision surgery and other longitudinal endpoints, with differences assessed using the log-rank test. Patients were censored at their last recorded clinical encounter, consistent with Kaplan-Meier methodology, and explicit loss to follow-up counts are not directly available within the TriNetX platform. Statistical significance was defined as a two-sided P value <0.05. All analyses were conducted using the native analytic and statistical tools available within the TriNetX platform. Results Study cohorts and propensity score matching After application of inclusion criteria and one-to-one propensity score matching, 19,265 patients with diabetic neuropathy and 19,265 patients without neuropathy who underwent lumbar laminectomy or laminotomy were included in the final analysis. Covariate balance improved substantially after matching, with standardized mean differences <0.1 for most variables. A modest residual imbalance remained for HbA1c [standard mean difference (SMD) 0.191]. Median follow-up duration differed between cohorts, with a median of approximately 1,710 days [4.7 years; interquartile range (IQR), 1,972 days] in the neuropathy cohort and 1,328 (3.6 years; IQR, 1,857 days) in the control cohort. Detailed baseline demographic, comorbidity, and laboratory characteristics before and after propensity score matching are summarized in Table S2. Medical complications and healthcare utilization Longitudinal outcomes at 1, 5, and 10 years following lumbar laminectomy or laminotomy are summarized in Table 1. At 1 year postoperatively, patients with diabetic neuropathy demonstrated significantly higher rates of major medical complications. Sepsis occurred in 2.8% of neuropathy patients compared with 1.6% of patients without neuropathy [risk ratio (RR) =1.78]. VTE occurred in 3.2% versus 2.2% (RR =1.48), myocardial infarction in 2.6% versus 1.9% (RR =1.36), and cerebral infarction in 3.1% versus 2.1% (RR =1.49). These differences persisted at 5 and 10 years, with neuropathy patients demonstrating consistently higher cumulative rates of thromboembolic and cardiovascular events across long-term follow-up. Table 11-, 5-, and 10-year outcomes in matched patients with and without diabetic neuropathy undergoing lumbar laminectomy/laminotomy (n=19,265)OutcomeTimepointPatient outcomes among patients with diabetic neuropathy, [n]Patient outcomes among patients without diabetic neuropathy, [n]Risk ratio95% CI of risk ratioRisk difference95% CI of risk differenceP valueSepsis1-year2.8% [547]1.6% [308]1.776(1.547, 2.039)0.012(0.009, 0.015)<0.0015-year9.4% [1,804]4.6% [887]2.034(1.881, 2.198)0.048(0.043, 0.053)<0.00110-year13.1% [2,527]6.2% [1,196]2.113(1.978, 2.257)0.069(0.063, 0.075)<0.001ED visit1-year24.7% [4,753]16.3% [3,147]1.510(1.451, 1.573)0.083(0.075, 0.091)<0.0015-year47.9% [9,239]32.2% [6,213]1.487(1.450, 1.525)0.157(0.147, 0.167)<0.00110-year53.3% [10,269]36.2% [6,967]1.474(1.441, 1.508)0.171(0.162, 0.181)<0.001PE/DVT1-year3.2% [626]2.2% [424]1.476(1.307, 1.667)0.010(0.007, 0.014)<0.0015-year7.5% [1,446]4.5% [860]1.681(1.549, 1.825)0.030(0.026, 0.035)<0.00110-year9.6% [1,844] 5.4% [1,041]1.771(1.646, 1.906)0.042(0.036, 0.047)<0.001Myocardial infarction1-year2.6% [498]1.9% [367]1.357(1.188, 1.551)0.007(0.004, 0.010)<0.0015-year8.0% [1,547]5.2% [1,009]1.533(1.420, 1.656)0.028(0.023, 0.033)<0.00110-year11.1% [2,148]6.8% [1,314]1.635(1.531, 1.746)0.043(0.038, 0.049)<0.001Cerebral infarction1-year3.1% [588]2.1% [395]1.489(1.312, 1.688)0.010(0.007, 0.013)<0.0015-year8.1% [1,570]4.8% [933]1.683(1.556, 1.820)0.033(0.028, 0.038)<0.00110-year10.7% [2,058]6.0% [1,165]1.767(1.649, 1.893)0.046(0.041, 0.052)<0.001Revision1-year3.3% [627]2.6% [503]1.247(1.110, 1.399)0.006(0.003, 0.010)<0.0015-year6.8% [1,312]4.6% [878]1.494(1.375, 1.624)0.023(0.018, 0.027)<0.00110-year7.7% [1,487]5.3% [1,016]1.464(1.355, 1.581)0.024(0.020, 0.029)<0.001Postlaminectomy syndrome1-year9.4% [1,819]6.7% [1,295]1.405(1.312, 1.504)0.027(0.022, 0.033)<0.0015-year17.9% [3,451]11.8% [2,271]1.520(1.447, 1.596)0.061(0.054, 0.068)<0.00110-year20.0% [3,857]13.0% [2,499]1.543(1.474, 1.616)0.070(0.063, 0.078)<0.001Postlaminectomy kyphosis1-year0.1% [15]0.1% [11]1.364(0.626, 2.968)0.000(0.000, 0.001)0.435-year0.2% [40]0.1% [25]1.600(0.971, 2.636)0.001(0.000, 0.002)0.0610-year0.2% [44]0.2% [29]1.517(0.950, 2.424)0.000(0.000, 0.002)0.07Recurrent stenosis1-year36.2% [6,979]28.8% [5,543]1.259(1.223, 1.296)0.075(0.065, 0.084)<0.0015-year54.0% [10,403]41.9% [8,079]1.288(1.261, 1.315)0.121(0.111, 0.131)<0.00110-year57.7% [11,113]44.4% [8,550]1.300(1.274, 1.326)0.133(0.123, 0.143)<0.001Post-op infection1-year2.1% [400]1.5% [280]1.429(1.228, 1.662)0.006(0.004, 0.009)<0.0015-year5.0% [961]2.9% [550]1.747(1.576, 1.937)0.021(0.017, 0.025)<0.00110-year6.3% [1,222]3.2% [607]2.013(1.830, 2.214)0.032(0.028, 0.036)<0.001CI, confidence interval; DVT, deep vein thrombosis; ED, emergency department; PE, pulmonary embolism. 1-, 5-, and 10-year outcomes in matched patients with and without diabetic neuropathy undergoing lumbar laminectomy/laminotomy (n=19,265) CI, confidence interval; DVT, deep vein thrombosis; ED, emergency department; PE, pulmonary embolism. ED utilization was significantly higher among patients with diabetic neuropathy at all timepoints. At 1 year, ED visits occurred in 24.7% of neuropathy patients compared with 16.3% of controls (RR =1.51). This difference persisted at 5 years (47.9% vs. 32.2%) and 10 years (53.3% vs. 36.2%), indicating a sustained increase in healthcare utilization among neuropathy patients. Infection and spine-specific complications Postoperative infection rates following lumbar laminectomy/laminotomy were higher among patients with diabetic neuropathy. At 1 year, infection occurred in 2.1% of neuropathy patients compared with 1.5% of controls (RR =1.43), with elevated rates persisting at 5 and 10 years. Neuropathy was also associated with higher rates of postlaminectomy syndrome and recurrent lumbar spinal stenosis. Postlaminectomy syndrome was diagnosed in 9.4% of neuropathy patients versus 6.7% of controls at 1 year (RR =1.41), with widening differences at 5 and 10 years. Diagnosis codes consistent with recurrent stenosis occurred in 36.2% of neuropathy patients compared with 28.8% of controls at long-term follow-up (RR =1.26). Postlaminectomy kyphosis was rare in both cohorts and did not differ significantly between groups at any evaluated timepoint. Revision surgery and repeat lumbar procedures Revision lumbar surgery occurred more frequently among patients with diabetic neuropathy. At 1 year, revision procedures were performed in 3.3% of neuropathy patients compared with 2.6% of patients without neuropathy (RR =1.25). This elevated revision risk persisted at 5 years (6.8% vs. 4.6%) and 10 years (7.7% vs. 5.3%), demonstrating a consistent long-term association between neuropathy and downstream surgical intervention. Similarly, rates of any repeat lumbar surgical procedure were higher among neuropathy patients across all follow-up intervals, indicating greater long-term procedural burden following laminectomy/laminotomy. Absolute risk differences were modest (2–3% at 10 years). Long-term analysis revealed persistent differences in revision-free survival extending to 10 years postoperatively. Kaplan-Meier estimates of revision-free survival through 10 years are shown in Table 2. Revision-free survival at 10 years was 88.4% in the neuropathy cohort compared with 91.3% in patients without neuropathy (log-rank χ2=45.8, P<0.001). Diabetic neuropathy was associated with a sustained increase in revision risk over long-term follow-up [hazard ratio (HR) =1.32; 95% CI: 1.22–1.43], indicating durable vulnerability beyond the early postoperative period. Table 2Kaplan-Meier analysis of 10-year revision-free survival after lumbar laminectomy/laminotomyCohortPatients in cohortPatients with outcomeMedian survival (days)Survival probability at end of time window, 10 years (3,650 days)Hazard ratio95% CIχ2dfPPatients with diabetes and neuropathy19,2651,487–88.35%–––––Patients without diabetes and neuropathy19,2651,016–91.30%–––––Log-rank test––––––45.7871<0.001Hazard ratio and proportionality––––1.316(1.215, 1.426)2.75710.09CI, confidence interval. Kaplan-Meier analysis of 10-year revision-free survival after lumbar laminectomy/laminotomy CI, confidence interval. Sensitivity analysis outcome To test the robustness of the primary findings, a sensitivity analysis was performed using a stricter comparator cohort restricted to patients with type 2 diabetes mellitus without complications (E11.9 only). After one-to-one propensity score matching, 13,007 patients with diabetic neuropathy were matched to 13,007 strict-control patients. Findings remained directionally consistent with the primary analysis. At 1 year, revision occurred in 3.8% of neuropathy patients versus 2.7% of strict controls, while ED utilization occurred in 22.2% versus 11.9%. At 5 years, revision occurred in 7.6% versus 4.7%, and ED utilization occurred in 45.8% versus 25.2%. At 10 years, revision occurred in 8.7% versus 5.2%, and ED utilization occurred in 52.3% and 28.4%. These findings support the robustness of the primary analysis despite using a more stringent comparator definition. Long-term outcome patterns Across all evaluated endpoints, diabetic neuropathy was associated with higher rates of medical complications, ED utilization, recurrent symptom diagnoses, and revision surgery at 1, 5, and 10 years following lumbar laminectomy or laminotomy. Notably, revision surgery and ED utilization demonstrated more consistent and durable differences than isolated perioperative complications, suggesting that neuropathy functions as a marker of sustained postoperative vulnerability rather than an early transient risk factor. Discussion Summary of findings In this nationwide propensity-matched cohort of patients undergoing lumbar laminectomy or laminotomy, diabetic neuropathy was associated with a consistently higher burden of adverse outcomes at 1, 5, and 10 years. At 1 year, patients with neuropathy experienced higher rates of sepsis at 2.8% compared with 1.6%, VTE at 3.2% compared with 2.2%, myocardial infarction at 2.6% compared with 1.9%, and cerebral infarction at 3.1% compared with 2.1%. Importantly, this signal was not limited to early medical events. Revision lumbar surgery occurred more frequently among neuropathy patients at 1 year, with rates of 3.3% versus 2.6%, and this difference persisted at 5 years, with rates of 6.8% versus 4.6%, and at 10 years, with rates of 7.7% versus 5.3%. ED utilization likewise remained elevated across all follow-up horizons, reaching 24.7% versus 16.3% at 1 year, 47.9% versus 32.2% at 5 years, and 53.3% versus 36.2% at 10 years. Taken together, these findings suggest that diabetic neuropathy is not simply a proxy for transient perioperative fragility, but rather a marker of sustained postoperative vulnerability and increased downstream healthcare utilization following lumbar decompression. Comparison to prior literature Lumbar decompression is widely regarded as an effective surgical treatment for symptomatic lumbar stenosis in appropriately selected patients, but long-term durability varies and late reoperation is an established reality in population-based cohorts (16). Diabetes has been repeatedly linked to higher complication rates after spine surgery and may attenuate patient-reported recovery in some settings, though much of the spine literature treats diabetes as a binary exposure (17,18). Our findings build on that foundation by specifically isolating diabetic neuropathy, rather than diabetes broadly, as the exposure of interest and demonstrating persistent associations with revision risk, recurrent symptom diagnoses (postlaminectomy syndrome and recurrent stenosis), and ED utilization over a full decade. This distinction matters because neuropathy likely captures a clinically relevant dimension of cumulative disease burden (microvascular dysfunction, impaired protective sensation, and altered neuromuscular control) that may not be reflected by glucose metrics alone. Potential mechanisms Several complementary pathways may explain why neuropathy tracks with higher long-horizon complication and revision burden after decompression. Of note, neuropathy is associated with impaired sensation and balance as well as altered gait mechanics, which could plausibly limit postoperative rehabilitation participation, increase fall risk, and perpetuate pain-related disability even when neural compression is addressed (19). Furthermore, neuropathy commonly coexists with microvascular disease and chronic inflammation, which are implicated in impaired tissue perfusion and delayed wound healing. These mechanisms may increase susceptibility to postoperative infection and downstream complication cascades (20,21). The persistent elevation in ED utilization we observed may reflect a higher prevalence of recurrent pain syndromes, residual numbness, or dissatisfaction with symptom durability in neuropathy patients, even when classic early surgical complications are not the primary driver (22). Prior spine surgery data suggest that postoperative ED visits are most commonly driven by pain-related complaints and other non-life-threatening issues rather than true surgical emergencies, supporting the interpretation that ED utilization may serve as a surrogate marker of unresolved symptom burden (23). In this context, the sustained ED signal observed in neuropathy patients likely reflects ongoing challenges in pain modulation and symptom interpretation following decompression rather than isolated technical failure. Additionally, increased ED utilization may also reflect surveillance bias, as patients with greater comorbidity burden are more likely to interact with the healthcare system, increasing the likelihood of diagnosis capture. It is also important to highlight that the increased incidence of recurrent stenosis diagnoses and revision surgery may be influenced by diabetes-associated vascular disease and neuromuscular impairment acting alongside progressive degenerative changes over time (24). However, for recurrent stenosis, it is important to recognize that these results likely reflect diagnosis coding frequency rather than confirmed structural recurrence and should be interpreted accordingly. Reduced microvascular perfusion and altered neuromuscular control may limit tissue resilience and functional recovery after decompression, increasing susceptibility to symptom recurrence despite adequate initial surgical relief. Over longer follow-up, these factors may compound age-related degenerative processes, contributing to a higher likelihood of repeat evaluation and subsequent surgical intervention. Clinical implications From a counseling standpoint, our data supports discussing neuropathy as a meaningful risk marker when setting expectations for both medical complications and longer-term durability after lumbar laminectomy or laminotomy (12). While the absolute differences in revision were modest (e.g., 7.7% vs. 5.3% at 10 years), the consistency of the signal across timepoints, paired with substantially higher ED utilization, suggests neuropathy patients may experience a greater cumulative symptom and healthcare burden after surgery. Practically, this may justify intensified perioperative optimization (cardiovascular risk mitigation, VTE prevention vigilance, wound-risk reduction strategies), and potentially more deliberate postoperative follow-up aimed at early identification of pain persistence, functional stagnation, or evolving recurrent stenosis (25,26). Strengths and limitations Several limitations warrant consideration. This study relies on administrative coding to define both exposure and outcomes, and ICD-10 coding does not capture the severity or clinical heterogeneity of diabetic neuropathy or distinguish between degrees of neurologic impairment. Similarly, diagnosis-based outcomes such as recurrent lumbar spinal stenosis likely reflect coding frequency rather than confirmed structural recurrence. Important clinical variables, including stenosis severity, number of decompressed levels, surgical technique, functional status, and duration of diabetes, were not reliably available within the database and therefore could not be accounted for. Although propensity score matching was performed and included laboratory and treatment-related variables such as HbA1c, insulin use, metformin use, and eGFR, a modest residual imbalance in HbA1c remained after matching. This likely reflects the intrinsic relationship between diabetic neuropathy and cumulative glycemic burden, as neuropathy represents a later-stage manifestation of systemic disease rather than an isolated condition, and residual confounding related to disease severity cannot be excluded (27). Median follow-up duration was shorter than the full 10-year analytic window and differed between cohorts; although Kaplan-Meier methods account for censoring, later timepoints are informed by a smaller subset of patients and should be interpreted with appropriate caution. Explicit loss to follow-up data is not available within the TriNetX platform. Patients are censored at their last recorded clinical encounter, and reasons for loss to follow-up cannot be determined. Additional stratified analyses, including by age, were not performed, as age was well balanced after matching and the cohort demonstrated a relatively narrow age distribution. Furthermore, increased healthcare utilization among patients with neuropathy may introduce surveillance bias, as more frequent clinical encounters increase the likelihood of diagnosis capture. Despite these limitations, the consistency of findings across multiple outcomes, timepoints, and sensitivity analyses supports the robustness of the observed associations. Conclusions In this propensity-matched national cohort, diabetic neuropathy was associated with higher rates of medical complications, ED utilization, infection, recurrent symptom diagnoses, and revision lumbar surgery through 10 years following laminectomy/laminotomy. These findings support treating neuropathy as a clinically useful risk marker when counseling diabetic patients, planning perioperative optimization, and setting long-term expectations for symptom durability after lumbar laminectomy/laminotomy. Supplementary The article’s supplementary files as Available at https://jss.amegroups.com/article/view/10.21037/jss-2026-1-0046/prf